Clinical Trial

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Study acronym: BRASIL
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-05; most recent amendment 2025-11-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-12
Trial Details
NCT Number NCT06867484
Lead Sponsor Youssef Zeidan
Collaborators: Boca Raton Regional Hospital
Conditions Breast Cancer, Cancer, Cancer of the Breast, HER2-negative Breast Cancer, ER+ Breast Cancer, Estrogen-receptor-positive Breast Cancer
Enrollment 114 participants
Start Date 2025-10-27
Primary Completion 2028-05 (estimated)
Study Completion 2033-05 (estimated)
Updated on ClinicalTrials.gov 2025-11-13